Editorial board disclosure policy

(Last updated March 2021)
 
All editors responsible for recommending or making publication decisions are requested to disclose on an annual basis any potential conflict of interest, including current or recent financial relationships with any commercial entity whose products or services may be contained in the journal content.
 
The following competing interests were disclosed:
 
John Aitken – Financial activities: I hold patents, am a shareholder in, and paid consultant for, a Sydney-based biotechnology company, Memphasys. Personal fees: I receive remuneration as a Steering Committee member for the Ferring Institute of Reproductive Medicine, a joint venture between Ferring Pharmaceuticals and the Chinese Academy of Science. Non-Financial Support: I am an honorary Chief Scientific Officer for the New Jersey-based biotechnology company, CellOxess. Intellectual property: I have filed patents in cell separation technologies that are invested in Memphasys. Involvement with other peer-reviewed publications: Editorial Board of Asian Journal of Andrology, Basic and Clinical Andrology and Reproductive Biomedicine Online.
 
Larry Chamley – Financial activities: Research Grant Auckland Medical Research Foundation, Research Grant Health Research Council of New Zealand, Research Grant Royal Society of New Zealand, Research Contract with Bayer (NZ) Animal Health Division. Personal fees: Consultant to V Abrahams/Lupus Research Institute Grant – Yale University. Involvement with other peer-reviewed publications: Director of the Hub for Extracellular Vesicle Investigations University of Auckland, Editorial Board of Trophoblast Research/Placenta, Editorial Board of American Journal of Reproductive Immunology, Editorial Board of The Journal of Reproductive Immunology.
 
Steve Charnock-Jones – Financial activities: I receive grant support from the Wellcome Trust, MRC, BBSRC and NIHR. Non-financial support: I receive support in the form of reagents and loaned equipment for the measurement of specific proteins in maternal blood. Intellectual property: I am a named inventor on a patent application relating to the identification of biomarkers that may be useful in pregnancy. Involvement with other peer-reviewed publications: Director of the Hub for Extracellular Vesicle Investigations University of Auckland, Editorial Boards of Trophoblast Research/Placenta, American Journal of Reproductive Immunology, The Journal of Reproductive Immunology, Chair, Publications Committee, American Society for Reproductive Immunology.
 
Carol Elias – Involvement with other peer-reviewed publications: Editorial Board member for Physiological Review, American Journal of Physiology and Journal of the Endocrine Society (no access to editorial decision for any). Frontiers System: Associate Editor for Frontiers in Endocrinology, Systems and Translational Endocrinology.
 
Greg FitzHarris – Financial activities: I hold research grants from government and private foundations. Personal fees: Occasional speaking honoraria. Intellectual property: submitted two patent applications relating to embryo biology (pending). One resulted in an industrial collaboration.
 
Niamh Forde – Financial activities: Research in my group is supported by the BBSRC, LTHT, GCRF-QR, STFC, UN-IAEA, University of Leeds. Personal fees: I consult to the UN-IAEA on an ad-hoc basis. Involvement with other peer-reviewed publications: I was a member of the SSR Publications committee until July 2019.
 
Steve Franks – Financial activities: Trustee, Genesis Research Trust (Imperial College; unpaid). Personal fees: Fee for grant review panel membership, Swedish Research Council 2020. Involvement with other peer-reviewed publications: Senior Editor, Endocrine Connections.
 
Robert Gilchrist – Financial activities: Work in my laboratory is support by grants and fellowships from the National Health and Medicial Research Council (NHMRC) of Australia. My lab receives collaborative research funds from City Fertility Centre Global Pty Ltd, and a scholarship from Virtus Health. I am a co-founder, co-director and shareholder of Anlagen Pty Ltd. Personal fees: I receive consultancy fees from City Fertility Centre Global Pty Ltd, and have received honoraria from CooperSurgical, Cook Medical and Rutgers Biomedical and Health Sciences. Non-financial support: International travel paid to attend CooperSurgical Scientific Advisory Board Meeting. Intellectual property: Patents: Gilchrist RB, Hussein T, Thompson JG, 'Modulation of granulosa cell apoptosis', WO 2007/009166A1, granted in Australia, patent number 2006272440; Albuz FK, Gilchrist RB, Thompson JG, 'Methods for the collection and maturation of oocytes', National Phase entry in Australia (2010246918), Canada (2,761,535), China (201080030583.2), Europe (10774437.7), India (9566/DELNP/2011), Japan (2012-510073), South Korea (10-2011-7030001) and the USA (13/320,245); Gilchrist RB, Chan K, Ledger WL, Milne-Robertson DM, Riepsamen AH, 'Gamete-secreted growth factors', PCT/AU2018/050064.
 
Peter Hansen – Financial activities: Research grants from NIH, USDA, Zoetis, Elanco, Select Sires, Balchem, Southeast Milk Inc, Florida Cattlemen’s Assn, Holstein Assn USA, and BARD. President and majority shareholder of Cooley Biotech LLC, Advisory Board for Micronutrients, Inc. Technical Advisory Group member and Chair for New Zealand Ministry of Business Innovation and Employment and DairyNZ Partnership – Pillars of a New Dairy Industry. Review panellist for NIH and USDA. Treasurer of Society for the Study of Reproduction, Board member for American Society of Animal Science, Past-President of International Congress of Animal Reproduction. Personal fees: Lecture fees from Hokkaido University, Society for Theriogenology, Phibro, Great Lakes Regional Dairy Conference, Sociedade Brasileira de Technologia de Embriões and Zoetis. Non-financial support: Travel paid for lectures for American Embryo Transfer Assn., American Dairy Science Assn., American Society of Animal Science. Intellectual property: Use of interferons to enhance fertility in farm animals; US Patent No. 4,997,646, issued March 5, 1991. Inventors: PJ Hansen, K Imakawa, RM Roberts, WW Thatcher. Involvement with other peer-reviewed publications: Editor, Plos One, Co-editor in-chief, Animal Reproduction Science, Editorial Board, Journal of Assisted Reproduction and Genetics, FASEB Journal and Journal of Animal Science and Biotechnology.
 
Karla Hutt – Financial activities: I have received grant funding from the NHMRC, NBCF and the ARC. Personal fees: Occasional speaking honoraria. Involvement with other peer-reviewed publications: Associate Editor for Human Reproduction, Reviewing Editorial Board for Biology of Reproduction.
 
Greg Johnson – Personal fees: I received and honoraria from the University of Florida, Institute of Food and Agricultural Sciences, Department of Animal Sciences, for presenting the Barron Lecture in Reproductive and Perinatal Biology Seminar. Involvement with other peer-reviewed publications: I served on the Board of Directors for the Society for the Study of Reproduction, and am a member of the Editorial Boards of Placenta and Domestic Animal Endocrinology.
 
Noora Kotaja – Involvement with other peer-reviewed publications: Editorial Board, Molecular and Cellular Endocrinology, Editorial Review Board, Environmental Epigenetics.
 
Jason Knott – Personal fees: In the next 12 months I will be traveling to give lectures or invited talks that might provide an honorarium.
 
Holly LaVoie – Financial activities: I have a patent application pending regarding the use of cumulus granulosa biomarkers in predicting IVF success. Involvement with other peer-reviewed publications: I serve on the Council for the Society for Experimental Biology and Medicine.
 
Tom Moore – Financial activities: I hold / have held interests in research grants, patents, start-up company. Personal fees: I am a paid employee of University College Cork. Non-financial support: My travel expenses to the Reproduction editorial board meeting and SRF conferences have been paid by the organisers. Intellectual property: Several patents discontinued, one pending.
 
Mary Mullins – Involvement with other peer-reviewed publications: Academic Editor at PLOS Biology and Associate Editor at PLOS Genetics.
 
Vasantha Padmanabhan – Financial activities: National Institutes of Health grant funding.
 
Karen Schindler – Financial activities: Research in my lab is supported by NIH funds. Personal fees: Occasional honoraria; course coordinator for Frontiers in Reproduction at the Marine Biological Laboratories. Involvement with other peer-reviewed publications: Editorial board member, Molecular Reproduction and Development; Board of Reviewing Editors, Biology of Reproduction.
 
Andy Vail – Financial activities: I have undertaken paid consultancy work for HFEA on several occasions to inform their Scientific and Clinical Advances Advisory Committee. The nature of the work has been review of clinical trial evidence for ‘add on’ therapies that feeds into their ‘traffic light’ system for public information (https://www.hfea.gov.uk/treatments/explore-all-treatments/treatment-add-ons/). Total fees to date have been under £20,000 and all is paid to my institution, University of Manchester, for my time. Involvement with other peer-reviewed publications: I am also a statistical editor for the Cochrane Gynaecology and Fertility Review Group.
 
Rao Veeramachaneni – Personal fees: Currently employed as Professor of Biomedical Sciences at Colorado State University, USA. Involvement with other peer-reviewed publications: Andrology, American Society of Andrology.
 
Erica Watson – Involvement with other peer-reviewed publications: Editorial review board, Environmental Epigenetics.
 
Joachim Wistuba – Involvement with other peer-reviewed publications: Associate editor, Molecular Human Reproduction; Editorial Board Member, Andrology.
 
The following editors reported no competing interests:
  • Nathalie Beaujean
  • Ian Brewis
  • Joëlle Dupont
  • Trudee Fair
  • Zuping He
  • Jacqueline Maybin
  • Chris Price
  • Joao Ramalho-Santos
  • Karl Swann
  • Kaiping Yang
 
Bioscientifica staff and freelancers working on the journal reported no conflicts of interest. Article authors' declarations are stated in each journal article. Referees must disclose any competing interests before agreeing to review any submission. For more information on the journal’s ethical policy, please read the ethical guidelines.
 
This policy follows the recommendations of the International Committee of Medical Journals Editors (ICMJE) and the Committee on Publication Ethics (COPE).